Patent ID: 7348354

Claim:
A cyclohexylurea compound corresponding to formula I: wherein n=0-3, m=0-2, X═O or S (where m=0), R 1 and R 2 are independently selected from the group consisting of H; C 1-8 alkyl and C 3-8 cycloalkyl, in each case saturated or unsaturated, branched or unbranched, mono- or polysubstituted or unsubstituted; aryl and heteroaryl, in each case mono- or polysubstituted or unsubstituted; and aryl, C 3-8 cycloalkyl or heteroaryl, in each case mono- or polysubstituted or unsubstituted, bound via C 1-3 alkylene, or R 1 and R 2 together form a ring and denote CH 2 CH 2 OCH 2 CH 2 , CH 2 CH 2 NR 6 CH 2 CH 2 or (CH 2 ) 3-6 , wherein R 6 is selected from the group consisting of H; C 1-8 alkyl and C 3-8 cycloalkyl, in each case saturated or unsaturated, branched or unbranched, mono- or polysubstituted or unsubstituted; aryl and heteroaryl, in each case mono- or polysubstituted or unsubstituted; and aryl, C 3-8 cycloalkyl or heteroaryl bound via C 1-3 alkylene, in each case mono- or polysubstituted or unsubstituted; R 3 is selected from the group consisting of C 1-8 alkyl and C 3-8 cycloalkyl, in each case saturated or unsaturated, branched or unbranched, mono- or polysubstituted or unsubstituted; aryl and heteroaryl, in each case unsubstituted or mono- or polysubstituted; and aryl, C 3-8 cycloalkyl and heteroaryl, in each case unsubstituted or mono- or polysubstituted, bound via a saturated or unsaturated, branched or unbranched, substituted or unsubstituted C 1-4 alkyl group; R 4 is selected from the group consisting of H, C 1-8 alkyl, saturated or unsaturated, branched or unbranched, mono- or polysubstituted or unsubstituted; and —(CH 2 ) o —W—(CH 2 ) p —H, wherein W═O, NR 7 or S, o=0-3, and p=0-4, and wherein R 7 is selected from the group consisting of H, C 1-8 alkyl, saturated or unsaturated, branched or unbranched, mono- or polysubstituted or unsubstituted; R 5 , if m≠0, is selected from the group consisting of: —(CH 2 ) q R 12 , —C(Y)-Z-R 12 , and —C(Y)—O-Z-R 12 , wherein Y═O, CH 2 or S, Z=C 1-8 alkyl, saturated or unsaturated, branched or unbranched, mono- or polysubstituted or unsubstituted, or (CH 2 ) q , wherein q=0-8, and R 12 is selected from the group consisting of H; C 3-8 cycloalkyl, aryl and heteroaryl, in each case unsubstituted or mono- or polysubstituted; or R 5 , if m=0, is selected from the group consisting of C 3-8 cycloalkyl, aryl and heteroaryl, in each case unsubstituted or mono- or polysubstituted, and —(CH 2 ) q R 12 , wherein q=0-8, and R 12 has the meaning given above; or a pharmaceutically acceptable salt thereof.